What is Susannah Gray's role at Theravance Biopharma, Inc.?

Susannah Gray reports to the SEC as director at Theravance Biopharma, Inc. (TBPH), according to the latest filing on September 25, 2026. Susannah Gray has also filed as director at 4D Molecular Therapeutics, Inc. (FDMT), director at Maravai Lifesciences Holdings, Inc. (MRVI), director at Anaptysbio, Inc (ANABV) and director at Morphic Holding, Inc. (MORF).

How many shares does Susannah Gray own?

After the latest filing that states it, Susannah Gray directly owned 216,200 shares of Maravai Lifesciences Holdings, Inc. (MRVI). Shares held through trusts, funds or family members are reported separately and are not counted here.

Has Susannah Gray bought or sold stock recently?

No open-market purchases or sales by Susannah Gray are on file. The filings report sale back to the company and grant or award.

How do I get alerts when Susannah Gray files?

Follow Susannah Gray on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Susannah Gray filed 1 time in the last 90 days.

Insiders · TBPH

Susannah Gray

Director at Theravance Biopharma, Inc. (TBPH) since February 2023

Susannah Gray has filed 31 insider reports with the SEC since April 2021, as director at Theravance Biopharma, Inc. (TBPH), director at 4D Molecular Therapeutics, Inc. (FDMT) and director at Maravai Lifesciences Holdings, Inc. (MRVI) and at 3 more companies. The latest filing, on September 25, 2026, reports sale back to the company at Theravance Biopharma, Inc. (TBPH).

Filings: 31
Companies: 6
Bought on market: None
Sold on market: None

Companies where Susannah Gray is an insider

Company	Role	Shares held	Price now	Last filing
TBPH Theravance Biopharma, Inc.	Directorsince February 2023	0		Sep 25, 2026
FDMT 4D Molecular Therapeutics, Inc.	Director		$12.46	Jun 18, 2026
MRVI Maravai Lifesciences Holdings, Inc.	Director	216,200	$7.86	May 28, 2026
ANABV Anaptysbio, Inc	Directorsince March 2026			Apr 29, 2026
MORF Morphic Holding, Inc.	Directorsince April 2021			Aug 20, 2024
APR Apria, Inc.	Directorsince May 2021			Mar 29, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Susannah Gray with

Other insiders at the same companies

Questions about Susannah Gray

What is Susannah Gray's role at Theravance Biopharma, Inc.?: Susannah Gray reports to the SEC as director at Theravance Biopharma, Inc. (TBPH), according to the latest filing on September 25, 2026. Susannah Gray has also filed as director at 4D Molecular Therapeutics, Inc. (FDMT), director at Maravai Lifesciences Holdings, Inc. (MRVI), director at Anaptysbio, Inc (ANABV) and director at Morphic Holding, Inc. (MORF).
How many shares does Susannah Gray own?: After the latest filing that states it, Susannah Gray directly owned 216,200 shares of Maravai Lifesciences Holdings, Inc. (MRVI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Susannah Gray bought or sold stock recently?: No open-market purchases or sales by Susannah Gray are on file. The filings report sale back to the company and grant or award.
How do I get alerts when Susannah Gray files?: Follow Susannah Gray on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Susannah Gray filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Susannah Gray (SEC CIK 0001833453). Totals count each trade once, skipping amendments whose original is on file, from Apr 29, 2021 on. View on SEC EDGAR